Showing results (2271-2280 of 3,422) with videos related to

Sort By:
Pageof 343
Eclinicalmedicine|June 23, 2025
Helicobacter pylori infection, anti-Helicobacter pylori treatment and risk of colorectal cancer and adenoma: an observational study and a meta-analysisXue Li, Huan-Qing Tao, Ji-Er Zhao, et al.
Eclinicalmedicine|June 23, 2025
Influence of a six-month home-based individualized physical activity intervention on carotid plaque instability measured by magnetic resonance imaging: a randomized controlled clinical trialMathilde Mura, Emeraude Rivoire, Leila Dehina-Khenniche, et al.
Eclinicalmedicine|September 24, 2025
Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27Maple Goh, Matt McEnany, Rachel Freeman, et al.
Eclinicalmedicine|September 22, 2025
Comparison of predictive tools for management of paediatric mild TBI: a prospective cohort studyFredrik Wickbom, Sarah Thornberg, Jorge Sotoca Fernandez, et al.
Eclinicalmedicine|September 19, 2025
The descriptive epidemiology of age at colorectal cancer diagnosis in Africa: a systematic review and meta-analysisNicholas Matovu, Helen G Coleman, Ines Mesa-Eguiagaray, et al.
Eclinicalmedicine|July 29, 2025
Dynamic versus fixed cerebral perfusion pressure targets in paediatric traumatic brain injury: a STARSHIP analysisC A Smith, S Y Bögli, M M Placek, et al.
Eclinicalmedicine|July 9, 2025
Prevalence of chlamydia, gonorrhoea, and trichomoniasis among male and female general populations in sub-Saharan Africa from 2000 to 2024: a systematic review and meta-regression analysisJulia Michalow, Lauren Hall, Jane Rowley, et al.
Eclinicalmedicine|July 9, 2025
Sustainable diets and cancer: a systematic review and meta-analysisMarina Kasper, Mirna Al Masri, Tilman Kühn, et al.
Eclinicalmedicine|July 9, 2025
Familial clustering of diabetic kidney disease and retinopathy in offspring of parents with type 1 diabetes: a population-based studyIsabella Herrlin, Fanny Jansson Sigfrids, Niina Sandholm, et al.
Eclinicalmedicine|July 17, 2025
A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerQiang Wen, Hao Yu, Mei Pan, et al.
Pageof 343